FDA advisory panel rejects widespread Pfizer booster shots

Over several hours of discussion, members of the Food and Drug Administration (FDA) panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses

from The Hindu - International https://ift.tt/2XyWdkY